Praluzatamab - CAS 2145109-70-0

Praluzatamab is a monoclonal antibody targeting an activated white blood cell adhesion molecule (ALCAM/CD116) . It is a naked antibody used to synthesize antibody active molecule conjugates (Praluzatamab ravtansine) and can be employed to study breast cancer.

ADC Antibody, Immunology/Inflammation related

Immunology/Inflammation, Antibody-drug Conjugate/ADC Related

2145039

1

-20°C

Ice Packs

Inhibitory Antibodies